Skip to main content
. 2021 Jun 8;7(7):e707. doi: 10.1097/TXD.0000000000001154

FIGURE 1.

FIGURE 1.

The practice of liver transplantation in patients with HIV/HCV in the DAA era in the United States. A, The annual number of LT recipients with HIV and as an overall percentage of all LTs is shown, further stratified by coinfection and HIV monoinfection. B and C, Stratification by HCC and cause of chronic liver disease, respectively. D, The geographic variation is demonstrated, by UNOS region, in LT practice for patients with HIV/HCV coinfection in the pre-DAA (2008–2012) and DAA (2014–2019) eras. The percentage of LTs in patients with HIV/HCV over all LTs in each respective region is shown. AI, autoimmune; ALD, alcohol-associated cirrhosis; DAA, direct-acting antivirals; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; HIV, human immunodeficiency virus; LT, liver transplantation; NASH, nonalcoholic steatohepatitis; UNOS, United Network for Organ Sharing.